Yeganeh Reuven
SEC insider (Form 3/4/5 filer). CIK 0002044677. Director & 10% Owner at BiomX Inc. (PHGE) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on Mar 17, 2026. Located in NESS ZIONA, IL.
Companies Yeganeh Reuven has filed insider reports for
- BiomX Inc. (PHGE): Director, 10% Owner
- Nukkleus Inc. (NUKK): Director, Officer, Chief Executive Officer
Yeganeh Reuven
CIK: 0002044677
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (36.4%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (18.2%)
Compensation grants
Other (G, F, J, C, D, …)5 (45.5%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Mar 17, 2026PHGE
BiomX Inc.
ConversionIndirect530K shares at avg. $2.00$1.1M - Mar 17, 2026PHGE
BiomX Inc.
SaleIndirect530K shares at avg. $5.00$2.6M - Mar 16, 2026PHGE
BiomX Inc.
SaleIndirect450K shares at avg. $5.00$2.3M - Mar 16, 2026PHGE
BiomX Inc.
ConversionIndirect450K shares at avg. $2.00$900K - Mar 13, 2026PHGE
BiomX Inc.
ConversionIndirect370K shares at avg. $2.00$740K - Mar 13, 2026PHGE
BiomX Inc.
SaleIndirect370K shares at avg. $5.00$1.9M - Mar 12, 2026PHGE
BiomX Inc.
ConversionIndirectSeries Y Convertible Preferred Stock
600 shares- - Mar 12, 2026PHGE
BiomX Inc.
SaleIndirect300K shares at avg. $5.00$1.5M - Mar 11, 2026PHGE
BiomX Inc.
ConversionIndirect300K shares at avg. $2.00$600K - Nov 13, 2025NUKK
Nukkleus Inc.
AwardDirect10K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 17, 2026 |  PHGE BiomX Inc. | Conversion | 530,000 | $2.00 | $1,060,000 | Indirect |
| Mar 17, 2026 | PHGE BiomX Inc. | Sale | 530,000 | $5.00 | $2,650,000 | Indirect |
| Mar 16, 2026 | PHGE BiomX Inc. | Sale | 450,000 | $5.00 | $2,250,000 | Indirect |
| Mar 16, 2026 | PHGE BiomX Inc. | Conversion | 450,000 | $2.00 | $900,000 | Indirect |
| Mar 13, 2026 | PHGE BiomX Inc. | Conversion | 370,000 | $2.00 | $740,000 | Indirect |
| Mar 13, 2026 | PHGE BiomX Inc. | Sale | 370,000 | $5.00 | $1,850,000 | Indirect |
| Mar 12, 2026 | PHGE BiomX Inc. | Conversion Series Y Convertible Preferred Stock | 600 | - | - | Indirect |
| Mar 12, 2026 | PHGE BiomX Inc. | Sale | 300,000 | $5.00 | $1,500,000 | Indirect |
| Mar 11, 2026 | PHGE BiomX Inc. | Conversion | 300,000 | $2.00 | $600,000 | Indirect |
| Nov 13, 2025 |  NUKK Nukkleus Inc. | Award | 10,000 | - | - | Direct |
1-10 of 11 transactions